1. Home
  2. TRVG vs CAPR Comparison

TRVG vs CAPR Comparison

Compare TRVG & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVG
  • CAPR
  • Stock Information
  • Founded
  • TRVG 2005
  • CAPR 2005
  • Country
  • TRVG Germany
  • CAPR United States
  • Employees
  • TRVG N/A
  • CAPR N/A
  • Industry
  • TRVG EDP Services
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TRVG Technology
  • CAPR Health Care
  • Exchange
  • TRVG Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • TRVG 278.1M
  • CAPR 324.6M
  • IPO Year
  • TRVG N/A
  • CAPR N/A
  • Fundamental
  • Price
  • TRVG $3.31
  • CAPR $6.25
  • Analyst Decision
  • TRVG Buy
  • CAPR Strong Buy
  • Analyst Count
  • TRVG 4
  • CAPR 8
  • Target Price
  • TRVG $4.50
  • CAPR $24.75
  • AVG Volume (30 Days)
  • TRVG 116.4K
  • CAPR 1.5M
  • Earning Date
  • TRVG 08-05-2025
  • CAPR 08-11-2025
  • Dividend Yield
  • TRVG N/A
  • CAPR N/A
  • EPS Growth
  • TRVG N/A
  • CAPR N/A
  • EPS
  • TRVG N/A
  • CAPR N/A
  • Revenue
  • TRVG $592,176,160.00
  • CAPR $13,392,150.00
  • Revenue This Year
  • TRVG $17.31
  • CAPR N/A
  • Revenue Next Year
  • TRVG $10.27
  • CAPR $6,061.53
  • P/E Ratio
  • TRVG N/A
  • CAPR N/A
  • Revenue Growth
  • TRVG 7.39
  • CAPR N/A
  • 52 Week Low
  • TRVG $1.60
  • CAPR $3.98
  • 52 Week High
  • TRVG $5.83
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • TRVG 42.58
  • CAPR 35.91
  • Support Level
  • TRVG $3.18
  • CAPR $6.90
  • Resistance Level
  • TRVG $3.44
  • CAPR $7.30
  • Average True Range (ATR)
  • TRVG 0.19
  • CAPR 0.54
  • MACD
  • TRVG -0.02
  • CAPR -0.11
  • Stochastic Oscillator
  • TRVG 21.62
  • CAPR 1.40

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: